AML Insights – November Update: What’s New in the Field

Explore key advances in acute myeloid leukemia, from targeted and epigenetic therapies to MRD-guided treatment, FLT3- and NPM1-directed strategies, and emerging cellular and gene-editing approaches shaping precision AML care.
Don’t miss these exciting developments!